OXAGEN

oxagen-logo

Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.

#SimilarOrganizations #People #Financial #Website #More

OXAGEN

Industry:
Biopharma Biotechnology Health Care Pharmaceutical

Founded:
1997-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.oxagen.co.uk

Total Employee:
51+

Status:
Active

Contact:
44 12 3584 1561

Email Addresses:
[email protected]

Total Funding:
130.74 M USD

Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail Fasthosts DNS Fasthosts


Similar Organizations

apogenix-logo

Apogenix

Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

john-bell_image

John Bell Development Advisory Board Chairman @ Oxagen
Advisor

anja-kรถnig_image

Anja Kรถnig Board Positions @ Oxagen
Board_member

john-bell_image

John Bell Non-Executive Director @ Oxagen
Board_member

Current Employees Featured

john-bell_image

John Bell
John Bell Co-Founder @ Oxagen
Co-Founder

mark-payton_image

Mark Payton
Mark Payton CEO @ Oxagen
CEO

graham-boulnois_image

Graham Boulnois
Graham Boulnois Chairman and a Director @ Oxagen
Chairman and a Director

Founder


john-bell_image

John Bell

Investors List

abingworth-management_image

Abingworth

Abingworth investment in Series C - Oxagen

mpm-capital_image

MPM Capital

MPM Capital investment in Series C - Oxagen

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series C - Oxagen

international-biotechnology-trust_image

International Biotechnology Trust

International Biotechnology Trust investment in Series C - Oxagen

advent-venture-partners_image

Advent Venture Partners

Advent Venture Partners investment in Series C - Oxagen

red-abbey-venture-partners_image

Red Abbey Venture Partners

Red Abbey Venture Partners investment in Series C - Oxagen

omega-funds_image

Omega Funds

Omega Funds investment in Series C - Oxagen

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series C - Oxagen

bessemer-venture-partners_image

Bessemer Venture Partners

Bessemer Venture Partners investment in Series C - Oxagen

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Series C - Oxagen

Official Site Inspections

http://www.oxagen.co.uk

  • Host name: 104.247.81.53
  • IP address: 104.247.81.53
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "Oxagen" on Search Engine